VEGF and PEDF in Patients With Myopic Choroidal Neovascularization
NCT02175940 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2014-06-26
Summary
This was a prospective, case-control study investigating aqueous levels of VEGF and PEDF in eyes with mCNV treated with IVB.
Conditions
- Myopic Choroidal Neovascularization
- VEGF Aqueous Level
- PEDF Aqueous Level
Sponsors & Collaborators
-
Ciro Costagliola
collaborator UNKNOWN -
Francesco Semeraro
collaborator UNKNOWN -
Roberto dell'Omo
collaborator UNKNOWN -
Mario R Romano
collaborator UNKNOWN -
Fabiana Aceto
collaborator UNKNOWN -
Rodolfo Mastropasqua
collaborator UNKNOWN -
Antonio Porcellini
collaborator UNKNOWN -
Università degli Studi di Brescia
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2014-01-31
- Completion
- 2014-05-31
Countries
- Italy
More Related Trials
-
Aqueous Vascular Endothelial Growth Factor (VEGF) Levels in Type 3 Neovascularization
NCT01350323 ·Status: COMPLETED ·Phase: NA
-
Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks
NCT00599820 ·Status: TERMINATED ·Phase: PHASE3
-
Intravitreal Conbercept Injection in Patients With Myopic Choroidal Neovascularization
NCT03971162 ·Status: COMPLETED ·Phase: NA
-
Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor
NCT03793400 ·Status: COMPLETED
-
Intravitreal Bevacizumab and Low Fluence Photodynamic Therapy
NCT00802126 ·Status: COMPLETED ·Phase: PHASE1
-
Intravitreal Bevacizumab for the Treatment of CNV in VKH Disease - A Prospective Study
NCT02015351 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Retreatments With Intravitreal Bevacizumab
NCT00406744 ·Status: TERMINATED ·Phase: PHASE3
-
Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular Degeneration
NCT00556348 ·Status: COMPLETED ·Phase: PHASE4
-
VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD)
NCT00727753 ·Status: COMPLETED
-
Bevacizumab Intravitreal for Myopic Choroidal Neovascularization
NCT00797992 ·Status: COMPLETED ·Phase: PHASE4
-
Intravitreal Bevacizumab for Low Vision in Neovascular Age-related Macular Degeneration (AMD)
NCT01327222 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion
NCT00709657 ·Status: TERMINATED ·Phase: NA
-
Study on the Biomarkers of Anti-VEGF Treatment for Choroidal Neovascularization
NCT06243406 ·Status: NOT_YET_RECRUITING
-
Intravitreal Bevacizumab in Agioid Streaks
NCT00406250 ·Status: COMPLETED ·Phase: PHASE1
-
Long-term Results After Intravitreal Bevacizumab Treatment Of Neovascular Age-related Macular Degeneration
NCT01027468 ·Status: COMPLETED ·Phase: NA
-
Intravitreal Bevacizumab for Nonproliferative Diabetic Retinopathy
NCT04511715 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Minocycline to Treat Branch Retinal Vein Occlusion
NCT01468831 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intravitreal Bevacizumab for Inflammatory Neovascular Membranes
NCT00407121 ·Status: WITHDRAWN ·Phase: PHASE3
-
Intravitreal Conbercept for Idiopathic Choroidal Neovascularization
NCT02857517 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Vascular Endothelial Growth Factor Blockers on Aqueous Humor Dynamics
NCT01994174 ·Status: TERMINATED
-
Study of the Long-Term Effect of Frequent Anti-VEGF Dosing on Retinal Function in Patients With Neovascular AMD
NCT00533689 ·Status: UNKNOWN ·Phase: PHASE3
-
Minocycline to Treat Central Retinal Vein Occlusion
NCT01468844 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of Retinal and Vascular Features in Macular Degeneration After Intravitreal Injections of Bevacizumab
NCT04138420 ·Status: COMPLETED
-
The Effects of Bevacizumab and Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration (AMD)
NCT00640640 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Treatment Response to Intravitreal Injection of Combined Propranolol and Bevacizumab Versus Bevacizumab Monotherapy in Patients With Wet Age Related Macular Degeneration :A Clinical Trial
NCT03609307 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3